eClinical Solutions Market Size & Share, Statistics Report 2034 

eClinical Solutions Market – By Solution, By Delivery Mode, By Clinical Trial Phase, By End Use & Global Forecast, 2025 to 2034

Report Content

Chapter 1&nbsp;&nbsp;&nbsp;Methodology and Scope

1.1&nbsp;&nbsp;&nbsp; Market scope and definition

1.2&nbsp;&nbsp;&nbsp; Research design

1.2.1&nbsp;&nbsp;&nbsp; Research approach

1.2.2&nbsp;&nbsp;&nbsp; Data collection methods

1.3&nbsp;&nbsp;&nbsp; Base estimates and calculations

1.3.1&nbsp;&nbsp;&nbsp; Base year calculation

1.3.2&nbsp;&nbsp;&nbsp; Key trends for market estimation

1.4&nbsp;&nbsp;&nbsp; Forecast model

1.5&nbsp;&nbsp;&nbsp; Primary research and validation

1.5.1&nbsp;&nbsp;&nbsp; Primary sources

1.5.2&nbsp;&nbsp;&nbsp; Data mining sources

Chapter 2&nbsp;&nbsp;&nbsp;Executive Summary

2.1&nbsp;&nbsp;&nbsp; Industry 360&deg; synopsis

Chapter 3&nbsp;&nbsp;&nbsp;Industry Insights

3.1&nbsp;&nbsp;&nbsp; Industry ecosystem analysis

3.2&nbsp;&nbsp;&nbsp; Industry impact forces

3.2.1&nbsp;&nbsp;&nbsp; Growth drivers

3.2.1.1&nbsp;&nbsp;&nbsp; Rise in government funding grants for clinical trials

3.2.1.2&nbsp;&nbsp;&nbsp; Growing demand for outsourcing clinical trials to CROs

3.2.1.3&nbsp;&nbsp;&nbsp; Increasing adoption of software solutions in clinical trials

3.2.1.4&nbsp;&nbsp;&nbsp; Increasing R&amp;D expenditure across the globe

3.2.2&nbsp;&nbsp;&nbsp; Industry pitfalls and challenges

3.2.2.1&nbsp;&nbsp;&nbsp; High implantation cost

3.2.2.2&nbsp;&nbsp;&nbsp; Low adoption and lack of awareness pertaining to eClinical solutions in developing countries

3.3&nbsp;&nbsp;&nbsp; Growth potential analysis

3.4&nbsp;&nbsp;&nbsp; Regulatory landscape

3.5&nbsp;&nbsp;&nbsp; Software landscape

3.6&nbsp;&nbsp;&nbsp; Porter&rsquo;s analysis

3.7&nbsp;&nbsp;&nbsp; PESTEL analysis

Chapter 4&nbsp;&nbsp;&nbsp;Competitive Landscape, 2024

4.1&nbsp;&nbsp;&nbsp; Introduction

4.2&nbsp;&nbsp;&nbsp; Company matrix analysis

4.3&nbsp;&nbsp;&nbsp; Competitive analysis of major market players

4.4&nbsp;&nbsp;&nbsp; Competitive positioning matrix

4.5&nbsp;&nbsp;&nbsp; Strategy dashboard

Chapter 5&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Solution, 2021 &ndash; 2034 ($ Mn)

5.1&nbsp;&nbsp;&nbsp; Key trends

5.2&nbsp;&nbsp;&nbsp; Randomization and trial supply management

5.3&nbsp;&nbsp;&nbsp; Clinical data management system (CDMS)

5.4&nbsp;&nbsp;&nbsp; Clinical trial management system (CTMS)

5.5&nbsp;&nbsp;&nbsp; Electronic clinical outcome assessment (eCOA)

5.6&nbsp;&nbsp;&nbsp; Electronic trial master file (eTMF)

5.7&nbsp;&nbsp;&nbsp; Electronic data capture (EDC)

5.8&nbsp;&nbsp;&nbsp; Other solutions

Chapter 6&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Delivery Mode, 2021 &ndash; 2034 ($ Mn)

6.1&nbsp;&nbsp;&nbsp; Key trends

6.2&nbsp;&nbsp;&nbsp; Licensed enterprise (on-premise) solutions

6.3&nbsp;&nbsp;&nbsp; Cloud-based (SAAS) solution (CBS)

6.4&nbsp;&nbsp;&nbsp; Web-hosted (on-demand) solution (WHS)

Chapter 7&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Clinical Trial Phase, 2021 &ndash; 2034 ($ Mn)

7.1&nbsp;&nbsp;&nbsp; Key trends

7.2&nbsp;&nbsp;&nbsp; Phase I

7.3&nbsp;&nbsp;&nbsp; Phase II

7.4&nbsp;&nbsp;&nbsp; Phase III

7.5&nbsp;&nbsp;&nbsp; Phase IV

Chapter 8&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By End Use, 2021 &ndash; 2034 ($ Mn)

8.1&nbsp;&nbsp;&nbsp; Key trends

8.2&nbsp;&nbsp;&nbsp; Contract research organizations (CROs)

8.3&nbsp;&nbsp;&nbsp; Medical device companies

8.4&nbsp;&nbsp;&nbsp; Pharma/biotech companies

8.5&nbsp;&nbsp;&nbsp; Hospitals and clinics

8.6&nbsp;&nbsp;&nbsp; Other end use

Chapter 9&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Region, 2021 &ndash; 2034 ($ Mn)

9.1&nbsp;&nbsp;&nbsp; Key trends

9.2&nbsp;&nbsp;&nbsp; North America

9.2.1&nbsp;&nbsp;&nbsp; U.S.

9.2.2&nbsp;&nbsp;&nbsp; Canada

9.3&nbsp;&nbsp;&nbsp; Europe

9.3.1&nbsp;&nbsp;&nbsp; Germany

9.3.2&nbsp;&nbsp;&nbsp; UK

9.3.3&nbsp;&nbsp;&nbsp; France

9.3.4&nbsp;&nbsp;&nbsp; Spain

9.3.5&nbsp;&nbsp;&nbsp; Italy

9.3.6&nbsp;&nbsp;&nbsp; Poland

9.3.7&nbsp;&nbsp;&nbsp; Switzerland

9.3.8&nbsp;&nbsp;&nbsp; Netherlands

9.4&nbsp;&nbsp;&nbsp; Asia Pacific

9.4.1&nbsp;&nbsp;&nbsp; China

9.4.2&nbsp;&nbsp;&nbsp; Japan

9.4.3&nbsp;&nbsp;&nbsp; India

9.4.4&nbsp;&nbsp;&nbsp; Australia

9.4.5&nbsp;&nbsp;&nbsp; South Korea

9.4.6&nbsp;&nbsp;&nbsp; Indonesia

9.4.7&nbsp;&nbsp;&nbsp; Thailand

9.5&nbsp;&nbsp;&nbsp; Latin America

9.5.1&nbsp;&nbsp;&nbsp; Brazil

9.5.2&nbsp;&nbsp;&nbsp; Mexico

9.5.3&nbsp;&nbsp;&nbsp; Argentina

9.5.4&nbsp;&nbsp;&nbsp; Argentina

9.5.5&nbsp;&nbsp;&nbsp; Chile

9.6&nbsp;&nbsp;&nbsp; Middle East and Africa

9.6.1&nbsp;&nbsp;&nbsp; South Africa

9.6.2&nbsp;&nbsp;&nbsp; Saudi Arabia

9.6.3&nbsp;&nbsp;&nbsp; UAE

9.6.4&nbsp;&nbsp;&nbsp; Egypt

Chapter 10&nbsp;&nbsp;&nbsp;Company Profiles

10.1&nbsp;&nbsp;&nbsp; Acralyon

10.2&nbsp;&nbsp;&nbsp; Anju Software (OmniComm System)

10.3&nbsp;&nbsp;&nbsp; Bio-optronics

10.4&nbsp;&nbsp;&nbsp; Clario

10.5&nbsp;&nbsp;&nbsp; Dassault Systemes (Medidata)

10.6&nbsp;&nbsp;&nbsp; Datatrak

10.7&nbsp;&nbsp;&nbsp; Ennov

10.8&nbsp;&nbsp;&nbsp; IBM

10.9&nbsp;&nbsp;&nbsp; Medsharing

10.10&nbsp;&nbsp;&nbsp; Multihealth Group (Clinfile)

10.11&nbsp;&nbsp;&nbsp; OpenClinica

10.12&nbsp;&nbsp;&nbsp; Oracle Corporation

10.13&nbsp;&nbsp;&nbsp; Parexel International

10.14&nbsp;&nbsp;&nbsp; Signant Health (CRF Health)

10.15&nbsp;&nbsp;&nbsp; Veeva Systems

&nbsp;&nbsp;&nbsp;

eClinical Solutions Market

Request Discount

Industries

Information

Link

Global Headquarters